Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05278494 · ClinicalTrials.gov registry record · NA
Dextromethorphan for Treatment of Postoperative Pain
A NA study of Postoperative Pain, sponsored by Nathanael Heckmann.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT05278494: Recruiting NA study of Postoperative Pain, sponsored by Nathanael Heckmann.
NCT05278494 is a NA study of Postoperative Pain that is actively recruiting participants, run by Nathanael Heckmann. The registered enrollment target is 160 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05278494, a NA study of Postoperative Pain, is actively recruiting participants, sponsored by Nathanael Heckmann.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Perioperative Dextromethorphan compared to Placebo for the Treatment of Postoperative Pain
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dextromethorphan Hydrobromide
Study Locations (1)
California
- Keck School of Medicine of USC - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-09-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05278494 shows while recruiting
NCT05278494 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05278494 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05278494 about?
NCT05278494 is a clinical study titled "Dextromethorphan for Treatment of Postoperative Pain". A Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Perioperative Dextromethorphan compared to Placebo for the Treatment of Postoperative Pain
What is the current status of trial NCT05278494?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2022-09-15. Estimated completion is 2026-12-31.
What conditions does trial NCT05278494 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT05278494?
The interventions under investigation include: Placebo (DRUG), Dextromethorphan Hydrobromide (DRUG).
Who is sponsoring clinical trial NCT05278494?
This trial is sponsored by Nathanael Heckmann, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05278494 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05278494's enrollment target sits among peer trials
160 33rd of 120 higher than 88 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI